Consumables & diagnostic services for detecting Barretts oesophagus and oesophageal cancer

Concepts

• pathology services
• gloucester
• medical consumables
• diagnostic service
• diagnostic services
• oesophageal cancer
• barretts oesophagus
• earlier detection
• barretts
• long-term service delivery

Location

Gloucestershire: Quayside Community Diagnostic Centre, Quayside House, Quay Street, Gloucester, GL1 2JN

Description

See section II.2.4.1 for details

Total Quantity or Scope

Provision of consumables and diagnostic service for detecting Barretts oesophagus and oesophageal cancer. Endoscopy for pre-cancer (Barretts) surveillance is an invasive, uncomfortable, costly and resource intensive procedure that has to be performed by a trained Endoscopy Consultant and team onsite at a hospital facility as it often requires patient sedation. By introducing a non-invasive procedure, the aim is to deliver significant benefits to patients, including earlier detection, reduced waiting times, and improved outcomes.The Trust plans to enter into a 12-month contract with a single supplier capable of providing both consumables and diagnostic services as an integrated solution. This initiative is not a product trial but rather a pilot project to assess the Trust's capacity and capability for long-term service delivery.This is a notice with the intention to award a contract under the most suitable provider process. This is a new service, with a new provider and the contract is expected to be live between June 2025 and June 2026.

Award Detail

Award Criteria

CPV Codes

• 85111800 - Pathology services
• 33140000 - Medical consumables

Legal Justification

This is a Provider Selection Regime (PSR) intention to award notice. The awarding of this contract is subject to the Health Care Services (Provider Selection Regime) Regulations 2023. For the avoidance of doubt, the provisions of the Public Contracts Regulations 2015 do not apply to this award. The standstill period begins on the day after the publication of this notice. Representations by providers must be made to decision makers by 30/05/2025. This contract has not yet formally been awarded; this notice serves as an intention to award under the PSR'.

Other Information

** PREVIEW NOTICE, please check Find a Tender for full details. ** This is a Provider Selection Regime (PSR) intention to award notice. The awarding of this contract is subject to the Health Care Services (Provider Selection Regime) Regulations 2023. For the avoidance of doubt, the provisions of the Public Contracts Regulations 2015 do not apply to this award. The standstill period begins on the day after the publication of this notice. Representations by providers must be made to the relevant authority by 9th June 2025. This contract has not yet formally been awarded; this notice serves as an intention to award under the PSR.Procurement Lead: Claire Thornton, Procurement Business Partner: Dan Kirkbride.No conflicts of interest were declared. The supplier selected is the only one who is able to provide both the capsule sponge and testing as one solution. The pathology element is proprietary to the supplier selected.